Search
Marker Therapeutics Inc
MRKRAdd to Watchlist
1.450USD
-0.020-1.36%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
24.21MMarket Cap
LossP/E TTM
Marker Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
3.55M
-46.19%
EPS(YoY)
-0.79
33.52%
Analyst Rating
BUY
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its total revenue reached 3.55M, with a year-on-year change of -46.19.
What are the current assets of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its current assets were 19.07M, with a year-on-year change of -13.40.
What are the total assets of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its total assets of Marker Therapeutics Inc were 19.07M, with a year-on-year change of -13.40.
What are the total liabilities of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its total liabilities of Marker Therapeutics Inc were 2.27M, with a year-on-year change of -34.36.
What is the total equity of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its total equity of Marker Therapeutics Inc was 16.80M, with a year-on-year change of -9.49.
What is the net financing of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its net financing of Marker Therapeutics Inc was 9.86M, with a year-on-year change of -34.20.
What is the Earnings Per Share (EPS) of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.79, with a year-on-year change of 33.52.
What is the net margin of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its net profit margin was -342.96, with a year-on-year change of -110.64.
What is the Return on Equity (ROE) of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -68.81, with a year-on-year change of -4.55.
What is the Return on Assets (ROA) of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -59.20, with a year-on-year change of -7.99.
What is the operating profit of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its operating profit was -12.44M, with a year-on-year change of -11.86.